WHO 2020 Classification of Small Round Cell Sarcomas
The WHO 2020 fifth edition introduced massive changes to bone tumor classifications. Consequently, Small Round Cell Sarcomas now represent a distinct category in oncology. This reclassification groups tumors based on unique molecular genetic characteristics rather than just morphology. Furthermore, the updated system establishes four distinct entities. These include Ewing sarcoma, CIC-rearranged sarcoma, BCOR-altered sarcoma, and EWSR1-non-ETS fusion sarcomas. Clinicians must understand these categories to deliver precise care.
Identifying Subtypes Through Molecular Characteristics
Each sarcoma subtype presents with specific clinical and pathologic findings. For instance, Ewing sarcoma primarily affects children and young adults. It typically displays moth-eaten lytic bone destruction. Moreover, aggressive periosteal reactions often accompany these lesions. In contrast, CIC-rearranged sarcomas appear as well-circumscribed soft-tissue masses. These tumors frequently show internal necrosis and hemorrhage. Therefore, radiologists should look for these distinct patterns during initial screening.
Imaging Features of Small Round Cell Sarcomas
Imaging plays a vital role in differentiating BCOR-altered sarcomas from other types. Specifically, these tumors often occur in adolescent boys as osteolytic or sclerotic lesions. They frequently involve the long bones or the pelvis. Additionally, extraosseous components often contain calcification. Conversely, EWSR1-non-ETS fusion sarcomas manifest as osteolytic lesions with cortical expansion. These lesions often show saucer-like surface erosion. Consequently, recognizing these features allows for earlier and more accurate diagnosis.
Clinical Implications and Prognostic Outcomes
The clinical management of these tumors varies significantly based on their molecular profile. For example, CIC-rearranged sarcomas are highly aggressive. They often respond poorly to standard Ewing sarcoma treatments. Thus, oncologists may decide on more intensive surgical interventions. On the other hand, BCOR-altered sarcomas may offer a more favorable prognosis. Identifying these through imaging helps clinicians provide patients with better prognostic information. Therefore, accurate radiologic-pathologic correlation is essential for modern oncology practices.
Frequently Asked Questions
Q1: What are the four types of undifferentiated small round cell sarcomas?
The four types defined by the WHO 2020 classification include Ewing sarcoma, CIC-rearranged sarcoma, BCOR-altered sarcoma, and sarcomas with EWSR1-non-ETS fusion genes.
Q2: Why is the radiologic identification of CIC-rearranged sarcomas important?
Identifying CIC-rearranged sarcomas is critical because they are highly aggressive. Furthermore, they often show a poor response to standard chemotherapy, necessitating different surgical strategies.
References
- Mori K et al. Undifferentiated Small Round Cell Sarcomas: Radiologic-Pathologic Correlation for the Updated WHO Classification Fifth Edition (2020). Radiographics. 2026 Apr undefined. doi: 10.1148/rg.250087. PMID: 41886300.
- Choi JH, Ro JY. The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities. Advances in Anatomic Pathology. 2021;28(1):44-58.
- Rajakulasingam R, et al. Imaging of bone and soft tissue BCOR-rearranged sarcoma. Skeletal Radiol. 2021;50(7):1301-1315.